Thursday 22 April 2021
Home      All news      Contact us      RSS      India
business-standard. - 2 month ago

Covaxin showed 81% interim efficacy: Bharat Biotech on Phase 3 results

The trials involved 25,800 participants, says the Hyderabad-based company


Latest News
Hashtags:   

Covaxin

 | 

showed

 | 

interim

 | 

efficacy

 | 

Bharat

 | 

Biotech

 | 

Phase

 | 

results

 | 

Sources